Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | Software (Web Marketplace Saas..) • IT (& TMT) • Media • FinTech (& Financials services) • Hardware (& Manufacturing) • Life Science • Oncology • Woman Focused |
Stages | Seed, Startup, Early Stage |
Investing | United States • United Kingdom • Germany • Switzerland • Austria • Europe |
Investment Range | €300,000 - €500,000 |
Assets Under Management | €10,000,000 |
APEX Ventures EuVECA GmbH & Co KG is a Vienna-based venture capital fund focused on deep-tech and medical sectors. They target founders who are deeply passionate about their work and possess technology with disruptive potential. Additionally, APEX Ventures seeks mission-driven, commercially focused entrepreneurs. They specialize in seed, startup, and early-stage investments, with equity expertise and a minimum investment range of €300,000 to a maximum of €500,000. The fund manages assets totaling €10,000,000 and is dedicated to building the next generation of world-leading companies. Their approach emphasizes the importance of closely collaborating with founders and offering more than just investment capital. APEX Ventures brings deep-tech expertise, experience, support, and a strong network to help startups scale and become globally competitive. The types of companies they invest in span across industries like Software (including Web, Marketplace, SaaS, etc.), IT & TMT, Media, FinTech & Financial services, Hardware & Manufacturing, Life Science, Oncology, and those focused on women. Their portfolio showcases their commitment to diversity in thought, experience, and background, aiming to leverage their profound resources and insights to guide their investees from passionate beginnings to successful acquisitions. The overarching theme of APEX Ventures’ investment thesis is to support deep-tech enterprises, emphasizing intellectual property and distinct commercialization paths, and to serve as a knowledgeable and experienced partner for European entrepreneurs in the deep-tech space.